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Abstract 
A two-stage thermal desorption/secondary electrospray ionisation/time-of-flight mass 
spectrometry for faster targeted breath profiling has been studied. A new secondary 
electrospray ionisation (SESI) source was devised to constrain the thermal desorption 
plume and promote efficient mixing in the ionization region.  Further a chromatographic 
pre-separation stage was introduced to suppress interferences from siloxanes 
associated with thermal desorption profiles of exhaled breath samples.  
In-vitro tests with 5-nonanone indicated an increased sensitivity and a lowered limit-of-
detection, both by a factor of ~4, the latter to an on-trap mass of 14.3 ng, equivalent to a 
sampled breath concentration of 967 pptv, Analysis of the mass spectrometric responses 
from 20 breath samples acquired sequentially from a single participant indicated 
enhanced reproducibility (reduced relative standard deviations (RSD) for 5-nonanone, 
benzaldehyde and 2-butanone were 28 %, 16% and 14% respectively. The corresponding 
values for an open SESI source were that 5-nonanone was not detected, with %RSD of 
39% for benzaldehyde and 31 % for 2-butanone.) 
The constrained source with chromatographic pre-separation resulted in an increase in 
the number of detectable VOC from 260 mass spectral peaks with an open SESI source 
to 541 peaks with the constrained source with pre-separation. Most of the observed 
VOC were present at trace levels, at less than 2.5% of the intensity of the base peak. 
Seventeen 2.5 dm3 distal breath samples were collected from asthma patients and 
healthy controls respectively, and subjected to comparative high-throughput screening 
using thermal desorption/SESI/time-of-flight mass spectrometry (TD-SESI-ToFMS). Breath 
metabolites were detected by using a background siloxane ion 
(Hexamethylcyclotrisiloxane m/z 223.0642) as an internal lockmass. 11 breath 
metabolites were selected from the breath research literature and successfully targeted. 
These data reinforce the proposition that TD-SESI-MS has potential for development as a 
rapid screening method for disease stratification and targeted metabolism profiling. 
Introduction 
In 1986 Fenn et al. noted the efficient electrospray ionisation (ESI) of volatile organic 
compounds (VOC)1, 2 Hill et al. subsequently interfaced an ESI source to an ion mobility 
spectrometer,3 and went on to show how VOC product ions could be generated by ESI for 
ion mobility spectrometry (IMS) determination and used the term secondary electrospray 
ionisation (SESI)4 to describe this process. The potential sensitivity of SESI was evident in 
the early descriptions of SESI with Hill and co-workers reporting a well-defined response 
(s/n >20) for cocaine from a mass flux of ca. 1 pg.s-1. 
In SESI-IMS the electrospray plume was directed into the reaction region of an ion 
mobility spectrometer that contained sampled narcotic vapours. The high-sensitivity of 
SESI was combined with a quadrupole-time-of-flight mass spectrometer (ToFMS), 
operating in the negative mode, to profile volatile fatty acids in exhaled breath samples.5 
Here, saturated and unsaturated fatty acids ranging from C3 to C14 in length were 
isolated at estimated concentrations in the order of 100 pptv; indicative of a high-
sensitivity assay. More recently, volatile fatty acid profiling has been used to identify 
individuals from a cohort of 65 participants with a global recognition score of 63% (43 
out of 65 correct) which suggests that this approach has the potential to distinguish and 
identify specific metabolic phenotypes.6   
Similarly, Cooks et al. described extractive electrospray ionisation (EESI) 7  based on 
mixing aerosol from a nebulised sample spray with an electrospray plume. The resultant 
interactions between electrospray droplets, ions and the aerosolised solution of analytes 
efficiently generated analyte ions. The potential utility of EESI was first demonstrated in a 
study that screened urine, surface waters and milk for trace-levels of pesticides and 
explosives. This study was a significant development in that proof-of-concept data were 
presented that highlighted high-speed quantitative assays of complex mixtures with 
substantial reductions in the resources, time and skill required to achieve high-fidelity 
analytical outcomes. The sensitivity of the approach and its tolerance of complex 
matrices was illustrated through the detection of 1 pmol of 1,3,5-trinitroperhydro-1,3,5-
triazine (RDX) spiked into undiluted mouse urine and 1 pmol of trinitrotoluene (TNT) 
spiked into polluted river water; based on EESI analysis without sample clean-up. The 
direct detection of volatile potentially genotoxic impurities by thermal desorption EESI 
combined with MS and IMS-MS has also been reporte.8,9 Coupling a gas chromatograph 
to an electrospray mass spectrometer has also been accomplished adding in a 
hyphenated separation to resolve complex mixtures. This was demonstrated using a 
multiple channel (7 emitter) ESI source in 1998,10 here the GC outlet was directed into 
the central electrospray emitter enabling eluted analytes to interact with the solvent 
before being electrosprayed. This novel approach was able to detect acylated aliphatic 
acids and was used to monitor a dehydrogenation of dimethylhydrazine in real-time. The 
combination of EESI-MS and atmospheric pressure chemical ionization (APCI-MS) with 
gas chromatography was used to detect a range of volatile organic compounds including 
pyridine, aminopyridine, n-vinylpyridine and the controlled substances 3,4-
methylenedioxy-N-methylamphetamine (MDMA) and 3,4-methylenedioxy-N-
ethylamphetamine (MDEA) by Brenner et. al. in 2008.11  Limits of detection for the 
pyridines were determined to be in the low picomole range indicating the sensitivity of 
the technique. 
 
 Breath profiling is an increasingly important approach to aid clinicians in diagnosing 
disease. Due to the non-invasive manner in which samples are collected, taking a breath 
sample can be part of a routine medical examination, giving it the potential to be used as 
a screening method for large populations. The importance of breath sampling and its 
capability to identify biomarkers for different diseases has been the subject of a number 
of review articles which highlight developments in clinical breath profiling.12-15 Breath 
sampling can be accomplished either offline using established lab-based techniques 
such as GC and GCxGC-ToFMS16 which can be coupled to preconcentration techniques 
such as thermal desorption to enable high resolution measurements on low 
concentration breath metabolites. The development of techniques such as proton 
transfer reaction-mass spectrometry (PTR-MS)17 and selected ion flow tube – mass 
spectrometry (SIFT-MS)18 has enabled monitoring of highly volatile species in real-time, 
providing diagnostic data in a very short timescale, however these techniques are less 
useful for the analysis of larger, less volatile species.   
The extension of EESI-MS to exhaled breath profiling19-24 was a logical development since 
it enables faster analysis times than GC-MS, while maintaining the ability to detect semi-
volatile species solvated in aerosol particles. In 2007 EESI was used for breath-by-breath 
monitoring of exhaled urea concentration.19 In the same year EESI was used to ionise 
non-volatile components such as carbohydrates in breath, thereby bridging the previously 
disparate approaches of exhaled breath condensate analysis and exhaled breath 
analysis.20 In a study of the breath of smokers, nicotine was detected at 50 pg m-3 using 
EESI.21 Translational research has used SESI-MS to monitor the pharmacokinetic 
behaviour of the epilepsy drug valproic acid with an on-line breath sampler interfaced to 
a electrospray source enabling the exhaled-breath concentration of valproic acid, and its 
metabolites/catabolites, to be tracked continuously with the result that the elimination 
profile of the drug was described in a non-invasive manner.24 The sensitivity and general 
applicability of ESI techniques for VOC analysis continue to be developed for a variety of 
mass spectrometer interfaces, and estimates for limits-of-detection (LOD) continue to be 
reported at ever diminishing levels’; recently claimed to be in the order of 28 fmol s-1 for 
cocaine.22  A study with 6 probe VOCs (methyl decanoate, octan-3-one, 2-ethylhexanoic 
acid, 1,4-diaminobutane, dimethyl methylphosphonate, and 2,3-butanediol), using a 
triple quadrupole mass spectrometer highlighted the importance of the operating 
parameters of the ionisation sources on the sensitivity of the analytical response with 
some indication that detection in the ppqv to pptv range was attainable.23  Such 
developments suggest that the limiting factors for trace-quantitation of VOC by ESI-MS 
are as likely to be associated with the challenge of generating VOC concentrations, 
reproducibly, at ppt(v) and lower, as with the design and optimisation of the ionisation 
and mass-spectrometric processes.  
It is helpful to note that GC-MS analysis of human breath has revealed a chemically 
complicated mixture with hundreds of VOC routinely isolated over approximately four-
orders of magnitude of concentration, and many of these compounds may only be 
detected if preconcentration approaches are adopted.25 There are a number of strategies 
for accomplishing preconcentration of volatiles before mass spectrometric analysis 
including thermal desorption (TD),25-27 solid-phase microextraction (SPME)28 and needle 
trap devices (NTD).29 These technologies have been used to take samples in clinical 
settings in conjunction with portable instrumentation.29 Thermal desorption with cold-
trapping followed by recovery by ballistic heating (referred to as two-stage thermal 
desorption) of VOC retained within adsorbent media is used widely with GC-MS 
instrumentation attaining 104 to 105 enrichment. 25-27 As well as the advantages of 
preconcentration, the adsorbent tubes used in TD approaches are portable, enabling 
large numbers of of breath samples to be taken at remote locations, and then returned 
to the laboratory for analysis. VOC trapped on sampling adsorbents are stable enough to 
be stored prior to analysis, although exactly for how long has yet to be established. 
Importantly, adsorbent tubes enable sterile single use and clinically safe sampling 
systems to be used to collect exhaled breath30 at the bedside, within the clinic or in the 
community. Previously the analysis of exhaled breath samples from human volunteer 
participants using a thermal desorption system hyphenated to a Waters Synapt HDMS 
ion-mobility mass spectrometer was described.31 With typical analysis times of 12 
minutes per sample claimed, the advantages of eliminating a lengthy GC separation 
stage (analysis times typically up to 90 min) for in-clinic applications were self-evident.  
In the current work the ionisation efficiency of the low concentration VOC components 
recovered by thermal desorption from sampled breath was studied. Two factors were 
identified as important in this regard: the ubiquitous presence of siloxanes in thermal 
desorption profiles from breath samples30 and the mixing of the thermal desorption 
profile into the ESI-source. Siloxanes sequester charge and supress analyte ion formation 
in the ESI source, and are a significant confounding factor in the development of 
targeted TD-ESI-MS assays for breath analysis. An open SESI interface is at risk from 
disruption from background contaminants and is difficult to set up to ensure the 
reproducible control of all the components in the SESI-system. 
Two developments were studied: a pre-separation stage with isothermal gas 
chromatography in the transfer line from the thermal desorption unit to isolate 
confounding siloxanes; and, a constrained SESI-source to ensure reproducible mixing 
and isolation of the SESI-region from background contamination. In-vitro studies with 5-
nonanone; a breath metabolite, enabled analytical figures-of-merit to be estimated 
before the comparative responses to 5-nonanone, benzaldehyde and 2-butanone in 
breath samples were evaluated. Finally, the feasibility of using TD-SESI-MS for targeted 
breath profiling was examined through the responses of this methodology to breath 
metabolites, previously indicated as potentially important32-34 candidates as markers of 
disease  
Methods and Materials 
Ethics, volunteer participants and breath samples 
This research was undertaken in accordance with the ethical principles of Good Clinical 
Practice and the Declaration of Helsinki. The breath samples were collected using a 
protocol approved by the local ethics advisory committee (Ref: Loughborough University 
G09-P5) from volunteer participants who gave informed consent. 
For the evaluation studies 20 2.5 dm3 exhaled distal breath samples were taken 
consecutively from a female participant at the Centre for Analytical Science at 
Loughborough University Chemistry Department. The 17 breath samples for the target 
compound evaluation trial were taken at the acute asthma clinic at Glenfield Hospital. 
Electrospray source modification 
The electrospray ionisation source of a ToFMS (Waters Synapt HDMS Waters, 
Manchester, UK) was modified to incorporate the outlet of a transfer line from a thermal 
desorption unit (Markes UNITY 1 Markes International, Rhondda Cynon Taff, UK). 
Reference experiments, using the configuration of the previous study were performed 
using the set-up shown in Figure1.31 The lockspray assembly was removed and the 
interlock switches were defeated to allow insertion of a 0.25 mm o.d. deactivated fused 
silica capillary from the transfer line into the source region; optimisation studies 
indicated that optimum sensitivity was achieved with the outlet capillary fixed at 
approximately 5 mm from the tip of the electrospray probe.  
The constrained electrospray design is also shown in Figure1. In this configuration the 
lockspray assembly was also modified as previously described. A 25 mm length of 
stainless steel tubing (8 mm o.d., wall thickness 1.5 mm) was aligned axially with the 
skimmer-cone inlet of the mass spectrometer and fitted so that the stainless steel tube 
was held in contact with the mass spectrometer sample cone to form a shroud to 
promote efficient mixing of the electrospray and thermally desorbed VOCs. The 
electrospray probe was axially aligned with the tube interface, spraying towards the mass 
spectrometer inlet cone, with the electrospray tip placed approximately 5 mm from the 
entrance of the tube. A 1 mm diameter hole in the tube interface centred approximately 
1 cm from the electrospray inlet end allowed the capillary from the transfer line to be 
inserted radially to a depth of approximately 1 mm into the constrained ionisation 
source.  
The transfer line from the thermal desorption unit was replaced with 1.5 m of 0.25 mm 
i.d. chromatography column with a  0.25 µm thick 5 % phenyl, 95 % methyl stationary 
phase of (DB-5MS GC column Agilent, Milford, US). This short length of column provided 
the pre-separation needed to retard the desorption profiles of the larger siloxanes, 
thereby supressing charge sequestration, and consequently enhancing further the 
sensitivity of the subsequent responses. 
Reagents and materials 
A 1 % (v/v) methanoic (HPLC grade, Fisher Scientific, Loughborough, UK) solution of 5-
nonanone (Sigma-Aldrich, Poole, UK) was prepared for the in-vitro characterisation study.  
The thermal desorption sample tubes were packed with Tenax®-Carbograph1 TD 
(Markes International, Swansea, UK: part number - C2-AXXX-5032). Thermal desorption 
tubes were prepared by conditioning them at 310ºC for 1 hr with a 100 cm3 min-1 flow of 
helium before sealing them. Breath Samples were collected using an adaptive breath 
sampler25 to collect 2.5 dm3 of exhaled distal air onto the thermal desorption sample 
tubes. The adaptive breath sampler was described previously by Basanta et. al.25. Briefly, 
breaths were monitored using an integrated pressure sensor, the output of which  was 
processed using analogue to digital conversion. The digital feed was input into a virtual 
instrument operating under LabviewTM that controlled two electrofluidic micro-valves. 
These valves ensured that a high-precision sampling pump (Escort Elf, MSA, Pittsburgh, 
USA), operating at a sample-flow of 1dm3min-1, was maintained at a constant operating 
flow throughout sample acquisitions. Digital signal processing was used to continuously 
analyse the breathing profile and control the switching signals to ensure that the portion 
of the exhaled breath corresponding to the distal airways was reproducibly sampled from 
each breath during the sampled period.  
TD-ESI-MS 
Table 1 summarises the operational parameters of the instrument systems.  The thermal 
desorption was operated without a split with a 1 min pre-purge at a temperature of 
300ºC for 5 min to a cold trap maintained at -10°C that concentrated the thermally 
desorbed volatiles. Injection was by ballistic heating of the cold-trap at 50 ºC s-1 to 300 
ºC; maintained for 3 min. The transfer line was maintained at 120º C, and the desorption 
flow through the cold-trap and transfer-line was 5 cm3 min-1 of purified helium.  
The mass spectrometer (Synapt HDMS Waters, Manchester, UK) was operated with the 
ion mobility function disabled. All experiments were performed in the positive ion mode 
over a mass range of m/z 50 to m/z 500.  
 
 
 
Results and Discussion 
The effect of a constrained source. 
The constrained source (Figure1) was implemented to contain and enhance the mixing of 
the electrospray and the thermal desorption plumes. The utility of doing this was 
characterised with a series of experiments involving the recovery of ca. 1 µg of 5-
nonanone from a conditioned thermal desorption tube (such a loading is equivalent to 
taking a 2.5 dm3 breath sample with a distal concentration of 70 ppbv). The 5-nonanone 
was spiked on to the adsorption tube with a 0.1 µl injection of 1% (v/v) 5-nonanone in 
methanol. The insert in Figure 2 compares the responses observed with the constrained 
SESI source against an open SESI configuration. The maximum intensity response 
increased from 1.7 kcount to 6.1 kcount (an increase of 3.7 times) and the integrated 
desorption profile increased from 23 kcount.s to 106 kcount.s (a 4.6-fold enhancement).  
The proof-of-concept study for the constrained source compared the 5-nonanone m/z 
143 (MH+) calibration and limits-of-detection for the constrained SESIsource with pre-
separation, against the open SESI source without pre-separation. The calibration was 
determined from the linear regression of m/z 143 (MH+) integrated ion intensity against 
analyte masses (mi) over the range 100 pg to 200 ng loaded on tube; equivalent to a 2.5 
dm3 breath sample of exhaled concentrations from ca.7 pptv to 13 ppbv. Equation 1 is 
the calibration obtained for the open SESI source configuration, and Equation 2 is the 
comparison for the constrained source with pre-separation; note that the values in the 
square bracket denote the 95 % confidence limits of the parameters.  
𝐼 (count) = 138[±207](count) + 15[±4.1](count ng-1) × 𝑚𝑖(ng);𝑅2 = 0.98 Eqn.1 
𝐼 (count) = −64[±223](count) + 55[±5.33](count ng-1) × 𝑚𝑖(ng);𝑅2 = 0.995 Eqn.2 
The limit of detection35  for 5-nonanone for the open source was estimated to be not 
more than 56 ng on tube mass, equivalent to a breath concentration of ca. 4 ppbv in a 
2.5 dm3 breath sample, and 14.3 ng on tube mass (967 pptv) for the constrained SESI 
source with pre-separation. The difference from 0 of the negative intercept for the closed 
source was not statistically significant, however it may be indicative of non-linear 
responses at low concentrations, and this is consistent with the reduction in the ion-
neutral collision frequency with a falling concentration combined with the constant 
residence time (ventilation rate) of the neutrals in the constrained ionisation volume. In 
this instance the constrained SESI source with separation was 3.7 times more sensitive 
with a limit of detection about a quarter as low again as that of the open SESI source 
without pre-separation. However such an evaluation does not address the confounding 
presence of siloxanes in breath samples with their high water loadings, to evaluate this 
phenomenon 20 breath samples taken sequentially from a volunteer participant were 
analysed.  
Pre-separation to inhibit siloxane charge sequestration. 
Siloxanes have been found to be ubiquitous contaminants in clinical breath samples.30 
and their high proton affinity results in charge sequestration and suppression of analyte 
ion formation.31 Indeed the cyclosiloxanes decamethylcyclopentasiloxane (m/z 371.0817 
[M+H]+) and dodecamethylcyclohexasiloxane (m/z 445.1040 [M+H]+) dominated ESI 
mass spectra acquired from breath samples reported previously.31 (They are also a 
significant feature in GC-MS chromatograms obtained from electron impact ionization, 
where they have been used as secondary retention indexing standards.30)  Substituting 
the deactivated capillary transfer line with 1.5 m of a 0.25 µm film thickness DB-5MS (5 
% phenyl, 95 % methyl) GC-column reduced the siloxane-based interference of the signal. 
With the transfer line temperature maintained at 120º C, it was possible to retard elution 
of decamethylcyclopentasiloxane and dodecamethylcyclohexasiloxane through the 
transfer line relative to other breath metabolites and hence enhance the ion production 
of the more volatile breath metabolites. Figure 2 compares mass selected thermal 
desorption profiles of breath samples obtained from open and constrained sources with 
and without a chromatographically active transfer line. With an open source and no pre-
separation in the transfer line an intense peak for the total ion signal (42 kcounts), with 
some minor features on its tail, was observed. Introducing a constrained SESI source 
with pre-separation in the transfer line resulted in several poorly resolved bands and an 
increase in the analysis time of approximately 3 min. Predictably, with the recovered VOC 
separated into distinct bands the maximum intensity of the total ion desorption signal 
(3.3 kcounts) reduced significantly. Nevertheless the signal-to-noise relationships for 
individual ions increased markedly, with a corresponding reduction in the siloxane 
interference intensities. For an open ESI with no pre-separation the maximum intensity of 
the dodecamethylcyclohexasiloxane (m/z 445.2) was ca. 18 kcounts, in contrast with a 
constrained source with pre-separation this reduced to 422 counts. Similarly the 
maximum desorption profile intensity for decamethylcyclopentasiloxane (m/z 371.2) 
reduced from 6 kcounts (open SESI no pre-separation) to 337 counts (constrained SESI 
with pre-separation). The reduction in the signals for the siloxane interferences was 
accompanied by increases in the signals for endogenous VOC. The example in Figure 2 
shows that the 5-nonanone (m/z 143.15) desorption profile obtained with the open SESI 
without pre-separation from breath samples was at best a discernable perturbation in 
the base-line, contrasted to a signal of 25 counts from the constrained source with pre-
separation for a similar sample. Acetone (m/z 59.05) showed a similar enhancement 
with 69 counts increasing to 415 counts and cyclohexenone and/or dimethylfuran (m/z 
97.07) increased from 27 counts to 86 counts. These observations support the 
proposition that the presence of high-proton affinity siloxanes result in charge 
sequestration and signal suppression for many exhaled breath metabolites. 
Comparison of the mass spectra obtained from the two systems, Figure 3, supports the 
claim that constrained SESI enhances ionisation and pre-separation suppresses charge 
sequestration by siloxanes. The mass spectra for the open SESI source with no pre-
separation show the significant presence of siloxanes see m/z 355, m/z 371, m/z 429 
and 445. In contrast these features are strongly supressed with a constrained SESI 
source with pre-separation. The features at m/z 355 and 371 are reduced by 98 %, 
2719 counts to 63 counts and 3413 counts to 74 counts respectively, while the 
interferent at m/z 429 was reduced from 529 counts to 34 counts, a 95.6% reduction, 
and finally at m/z 445 the signal was reduced from 1360 to 108 a 92.8% reduction. The 
effect in the chemical information content, (or chemical space) within the desorption 
profile may be discerned from the cumulative distribution function (CDF), also shown in 
Figure 3. The mass spectra in Figure 3 were filtered to remove noise, so signals below  
the limit-of-detection were removed and a histogram of peak intensity vs. m/z was 
produced.The resultant CDF for the open SESI-source showed distinct step-like features 
associated with the siloxane species, and in contrast to the constrained SESI with pre-
separation, there are m/z ranges where the contribution to the CDF was supressed. In 
fact from about m/z 200 upwards the contribution was almost exclusively due to 
siloxanes species accounting for ca. 1/3 of the total response. The constrained source 
generated responses across the whole mass range and the increase in analytical space 
that resulted may be discerned. Further study of the intensity of the ions observed from 
the two sources reveals that the constrained SESI source with pre-separation resulted in 
significant increases in the number of ions observed at low concentrations, see Figure 4. 
In Figure 4 the mass spectra in Figure 3 were characterised in terms of the total number 
of analytical features (peaks) observed over a given normalised intensity range. For 
97.5% of the normalised intensity range from 0.025 upwards to 1 the distributions of the 
number of mass spectral peaks observed was essentially the same for both approaches. 
However what was clear was that the greatest number of analytical features were to be 
observed at the lowest intensities. Significantly more analytical features were observed 
using the constrained SESI source with pre-separation.  The open SESI without pre-
separation yielded 260 mass spectral peaks, of which 179, (69%) were present at a 
normalised intensity of equal to or less than 0.025. In contrast the constrained source 
yielded 541 peaks, with 448 (83%) present at intensities equal to or less than a 
normalised intensity of 0.025.  
Reproducibility  
Reproducibility measurements were based on 20 replicate breath samples collected 
sequentially from a healthy volunteer. 10 samples selected randomly  were analysed by 
each of the techniques and the reproducibility compared. Figure 5 compares responses 
obtained for 5-nonanone, (m/z 143.03), benzaldehyde (m/z 107.12) and 2-butanone 
(m/z 73.08), and in this figure the selected-ion thermal desorption profiles are 
normalised to the group average enabling the differences in signal to noise and 95 % 
confidence limits to be evaluated. The enhancement in sensitivity and reproducibility 
obtained from the constrained source with pre-separation is evident. The relative 
standard deviations (RSD) obtained for 5-nonanone, benzaldehyde and 2-butanone from 
the constrained source with pre-separation were 28 %, 16% and 14% respectively, and 
the corresponding values for the open source were that 5-nonanone was not detected, 
with RSDs of 39% for benzaldehyde and 31 % for 2-butanone. 
Clinical pilot 
The final test undertaken was a pilot study to assess the feasibility of adopting this 
approach for targeted breath profiling. 17 exhaled breath samples were obtained from 
volunteers attending or working at a severe asthma clinic (Glenfield Hospital, Leicester, 
UK). 10 samples were analysed by TD-SESI-ToFMS with a constrained source with pre-
separation and 7 were analysed with TD-SESI-ToFMS with an open source and no pre-
separation.  11 VOC, reported previously in breath profiling studies of respiratory 
disease36-39   , were selected as target compounds and the thermal desorption profiles 
were screened in the positive mode for protonated product ions.  
Table 2 is a summary of the endogenous breath VOC identification from the two sets of 
data. It was not always possible to obtain  accurate mass measurements (<15 ppm) in 
the absence of a low m/z lock mass ion. The constrained source with pre-separation 
enabled 1-hydroxyacetone, 3-buten-2-one, and acetone to be observed in all samples. 
2,3-Butanedione, butanone, pentanal, benzaldehyde, isoprene, and trimethylamine were 
observed in 9 of the samples with dimethylsulfide present 80 % of the time in 8 samples 
and finally dimethylamine was observed in 3 samples, 30%. In contrast acetone and 
dimethylamine  were observed in all the samples analysed with the open source with no 
pre-separation. 1-Hydroxyacetone, butanone and isoprene were observed in 6 of the 7 
samples (86%). Benzaldehyde (71%), dimethylsulfide (71%), 3-buten-2-one (57%), 
trimethylamine (57%), 2,3-butandione (43%) and pentanal (43%) all appeared to be 
observed less frequently compared to the constrained source with pre-separation. 
In those instances when it was possible to assign ions on the basis of accurate mass (to 
within 15 ppm of the monoisotopic mass), the thermal desorption profile was integrated 
and the mean responses in Table 2 indicate that the constrained source with pre-
separation resulted in a higher proportion of accurate masses and more sensitive 
responses. 
Conclusions 
Constraining the dispersal of the analyte plume and promoting mixing into the 
electrospray ion jet combined with a pre-separation stage results in larger numbers of 
VOC being observed in exhaled breath. Further the responses appear to be more 
sensitive with a higher reproducibility. 
The significant increase in the numbers of VOC observed with the constrained SESI with 
pre-separation emphasises and that changes in sampling and/or ionisation and/or 
detection are likely to exert profound effects on the quantity of available metabolic 
information recovered during a study. Just how many VOC are present in a typical breath 
sample and at what concentrations has yet to be determined. When ambient ionisation 
approaches are adopted the potential of charge transfer processes within the ionisation 
source to bias responses to compounds with higher proton affinity needs to be 
addressed; the increase in proportion of dimethylamine observations from the open 
source for example, Table 2. The central importance for systemic control and self-critical 
approaches to quality assurance in metabolomic-based breath profiling studies are 
highlighted here. Certainly, reporting on the numbers and distribution of analytical 
features associated with breath profiling methods would assist in data evaluation, and 
consolidation of research findings. This is particularly important with ambient ionisation 
techniques where selective ionisation and ion suppression effects can have a dramatic 
effect on the mass spectral response. 
This study indicates that faster targeted analysis of trace VOC in breath is possible by TD-
SESI-MS, with the use of a constrained electrospray plume in conjunction with pre-
separation to isolate the breath volatiles from siloxane contaminants. This technique 
appears to have potential as a rapid screening method for biomarkers in breath in the 
ppt(v) to ppb(v) range with analysis times of ca. 12 min, and although this study 
addresses only a small number of analytes from a limited number of participants, this 
does demonstrate proof-of-priciple andmerits further development. The next challenge is 
to develop the ionisation systems for VOC that do not form ions in a SESI source, so that 
these species can be included in this approach.  
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Tables 
Table 1. Summary of the mass spectrometer operating parameters 
Parameter Open Source Constrained Source 
Thermal desorption     
Desorption flow 5 cm3 min-1 5 cm3 min-1 
Sample-trap leak-test  0 to -1 min 0 to -1 min 
Sample trap pre-purge 1 to 2 min 1 to 2 min 
Sample trap desorption 2 to 6 min 2 to 6 min 
Desorption temperature 300 °C 300 °C 
Desorption split Splitless  Splitless  
Cold trap temperature -10 °C -10 °C 
Cold-trap pre-purge 6 to 7 min 6 to 7 min 
Cold-trap secondary desorption 7 to 10  min 7 to 10  min 
Cold-trap heating rate  50 °C  s-1 50 °C  s-1 
Cold-trap desorption temperature 300 °C 300 °C 
Cold-trap cooling 10 to 11 min 10 to 11 min 
Sample-trap cooling 6 to 10 min 6 to 10 min 
Mass spectrometer     
Capillary voltage 3 kV 3 kV 
Sample cone voltage 20 V 20 V 
Extraction cone voltage 4 V 5 V 
ESI solvent flow rate 5 µl min-1 5 µl min-1 
Desolvation temperature 200 °C 120 °C 
Source Temperature 120 °C 120 °C 
Desolvation gas flow 500 dm3 hr-1 100 dm3 hr-1 
Cone gas flow 0 dm3 hr-1 20 dm3 hr-1 
 
  
Table 2 Summary of breath analyte detection and analysis. 
Metabolite 
 Closed source with pre-
separation 
Open source no pre-
separation 
M 𝑴� ; 95%  a%  𝑹� 
(AU) 
𝑴� ; 95%  b%  𝑹� 
(AU) 
        
1-Hydroxyacetone 75.045 74.9; 0.2 100 2.89 75.042; 0.001 86 1.6 
3-Buten-2-one 71.05 71.05; 0.01 100 4.92 71.047; 0.001 57 3.8 
2,3-Butanedione 87.045 87.044; 0.001 90 7.58 87.042; 0.001 43 3.0 
Butanone 73.065 73.06; 0.01 90 7.28 73.06; 0.01 86 3.2 
Pentanal 87.081 87.06; 0.01 90  87.08; 0.01 43  
Benzaldehyde 107.05 107.06; 0.01 90 6.12 107.048; 0.001 71 4.9 
Acetone 59.05 59.049; 0.001 100 9.79 59.047; 0.001 100 2.4 
Isoprene 69.070 69.070; 0.001 90 10.37 69.068; 0.001 86 14 
Trimethylamine 60.081 60.06;  0.03 90 0.39 60.073; 0.01 57  
Dimethylsulfide 63.027 63.01; 0.03 80  62.999; 0.002 71  
Dimethylamine 46.066 46.065; O.001 30 1.26 46.063; 0.001 100  
Note:  M: nominal mass, 𝑴� ; 95%: mean observed mass; 95 % confidence limit, % 
percentage of samples found with target compound in, a f 10 samples with the 
constrained source,  and b 7 samples with the open source, 𝑹�  (AU) mean 
response (au: arbitrary units)  from those analyses where the observed mass was 
within 50 ppm of the nominal mass..    
Figures 
 
 
Figure 1.  Top left insert an unconstrained thermal desorption SESI interface. (Reprinted 
with permission from Reynolds, J.C; Blackburn, G.J; Guallar-Hoyas, C; Moll, V.H; 
Bocos-Bintintan, V; Kaur-Atwal, G; Howdle, M.D; Harry, E.L; Brown, L.J; Creaser, 
C.S; Thomas, C.L.P, Anal. Chem., 2010, 82, 2139. Copyright (2010) American 
Chemical Society) 
Top right a functional schematic of the experimental set up 
Bottom.  Constrained source showing the mass spectrometer inlet manifold (A) and mass 
spectrometer inlet cone (B)modified by attaching a 2 cm length of 8 mm diameter 
stainless steel tubing (C), wall thickness 1.5 mm, with a  1 mm hole to enable the 
transfer line from the thermal desorption unit to be inserted ca. 1 cm from the 
entrance to the inlet tube (D).  The electrospray probe was offset by ca. 5 mm and 
axially aligned with the stainless steel tube (E). 
 Figure 2 Mass selected thermal desorption profiles showing the effect on sensitivity of 
introducing a constrained source with pre-separation. Inset: selected ion 
desorption profile [M+H]+ of 5-nonanone standard, indicating the enhancement of 
the ion signal from constraining the source without pre-separation. LHS traces 
compare open source responses without pre-separation to RHS traces showing 
constrained sources with a pre-separation step. Figures indicate scaling of signal. 
From top-to-bottom: total ion trace (x 0.25); dodecamethylcyclohexasiloxane (m/z 
445.2, x 1) decamethylcyclopentasiloxane (m/z 371.2, x1); nonan-5-one (m/z 
143.15, x100) acetone (m/z 59.05, x25) and cyclohexenone  (m/z 97.07, x25).  
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 Figure 3. Mass spectra (bottom), and their cumulative distribution functions, (F(x) vs. m/z 
from breath samples taken from the same participant, at approximately the same 
time illustrating the effect of constraining the SESI source with pre-separation on 
the resultant data. The large siloxane responses were effectively supressed, and 
their distortion of the cumulative distribution function eliminated. Note the 
increased chemical space associated with the constrained SESI source with pre-
separation; arising from a significant increase in number of lower intensity signals 
observed, see Figure 4. 
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 Figure 4. Distribution of responses against normalised intensity . Circles show the number 
of analytical features over normalised interval for the constrained SESI source 
with pre-separation, and open diamonds show the comparison data from the 
open SESI source without pre-separation. Insert, a histogram showing  a close up 
of the first 10 % of the normalised response range. Black constrained SESI with 
pre-separation and white open SESI without pre-separation. Using the constrained 
SESI source with pre-separation resulted in significantly increased numbers of low 
concentration VOC in exhaled breath being observed, without affecting the 
responses to the higher level components. 
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Figure 5 Composite offset selected ion thermal desorption profiles of replicate breath 
samples showing ion selective signal intensity ( 𝑰 ) normalised to the mean 
maximum intensity of the ion ( 𝑰�𝒎𝒎𝒎). The 95% confidence limits are indicated 
with dashed lines. The left hand traces were obtained from the constrained  
source with pre-separation and the right from the open source. Top: 5-nonanone 
(143.03), middle:  benzaldehyde (m/z 107.12), and bottom butanone (m/z 
73.08). The variations in sensitivity, and reproducibility of the responses to these 
three breath volatiles are evident. 
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